Newsroom, your daily review

Keep up with the latest in the tableting community!


Feature article

CMAC's Digital Medicines Manufacturing

March 21, 2023

Webinar - From particles to drug product performance and stability

March  21st, 3.30pm (GMT)

"From particles to drug product performance and stability"

#webinar #particle #stability #DM2 #STYL'One Nano

Publish with us!

Interesting news to share with the community?
Carried a new study out?
This newsfeed is yours, do not hesitate!

Announcement

MySTYL'One

March 17, 2023

Compaction characterisation of piroxicam amorphous solid dispersions formulations


MySTYL'One user exclusive!

This new bulletin available details a study on a compaction characterisation from a combined formulation of Piroxicam amorphous solid dispersionns and Kollitab™ DC 87 L.

#Amorphous Solid Dispersion #KTab #Characterisation #compaction simulator #STYL'One Nano

Got questions? Ask your peers!

Feature article

Cambrex

March 16, 2023

Pediatric dosage forms: Rising demand for pediatric dosage forms requires reformulation and development expertise but also to-scale manufacturing capabilities

Pharmaceutical companies are looking to pediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. The desire to develop pediatric dosage forms (PDFs) of drugs with existing adult indications has two main drivers: (1) the US Food and Drug Administration’s (FDA’s) role in limiting off-label use in pediatric patients, which aligns with the FDA’s role in ensuring the safety and efficacy of approved products for all patients; and (2) sustaining revenue growth through ...

Pharmaceutical companies are looking to pediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. The desire to develop pediatric dosage forms (PDFs) of drugs with existing adult indications has two main drivers: (1) the US Food and Drug Administration’s (FDA’s) role in limiting off-label use in pediatric patients, which aligns with the FDA’s role in ensuring the safety and efficacy of approved products for all patients; and (2) sustaining revenue growth through pediatric exclusivity that typically adds 180 days of intellectual property protection and thus almost 6 additional months of branded drug sales, which in some cases could translate to billions of dollars in revenue.

#scale-up #manufacturing #pediatric drug development #dosage form

Announcement

MySTYL'One

March 13, 2023

The Assessment of the Capping Tendency of the Tablet during The Pharmaceutical Tabletting Using Finite Element Analysis in Computational Modelling Tools


In this paper you will find a study that focuses on the assessment of the capping problem using computer modelling of the pharmaceutical powder compression and consolidation process using the finite element analysis (FEA) method implementing the Drucker–Prager Cap (DPC) model. The paper is available in the PAPERS section.

Find others papers here and learn about

  • Characterization of Tableting Speed-Dependent Deformation Properties of Active Pharmaceutical Ingredients in Powder Mixtures Using Out-...

In this paper you will find a study that focuses on the assessment of the capping problem using computer modelling of the pharmaceutical powder compression and consolidation process using the finite element analysis (FEA) method implementing the Drucker–Prager Cap (DPC) model. The paper is available in the PAPERS section.

Find others papers here and learn about

  • Characterization of Tableting Speed-Dependent Deformation Properties of Active Pharmaceutical Ingredients in Powder Mixtures Using Out-of-Die Method
  • Influence of the unloading conditions on capping and lamination: Study on a compaction simulator
  • Shear strength of pharmaceutical tablets: Theoretical considerations, evaluation and relation with the capping tendency of biconvex tablets

#STYL'One #Powder compaction #Drucker-Prager Cap model #capping

Feature article

Korsch AG

March 6, 2023

KORSCH acquires MEDELPHARM to strengthen R&D product line

KORSCH AG, the global leader in tablet press technology, offering solutions for product development, scale-up, high-speed production, multi-layer, continuous manufacturing, and high-containment applications – has announced the acquisition of MEDELPHARM, the innovator and global leader in compaction simulator technology.

#R&D #KORSCH #MEDELPHARM #range

Feature article

MySTYL'One

March 2, 2023

Webinar replay on demand - Assessing temperature influence on tablet quality attributes

Get access for this online event replay.

Date: Tuesday, February 28th, 2023
Time: 3pm (Paris time)
Duration: 60 minutes

"Assessing temperature influence on tablet quality attributes - Using a temperature-controlled die on the STYL’One Evo compaction simulator" - by Hanna Grumann, PhD student at the Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Düsseldorf, Germany under the supervision of Prof. Peter Kleinebudde.


#STYL'One evo #compaction simulator #sticking #picking #temperature influence #webinar

Feature article

Parmaceutical manufacturer

Feb. 27, 2023

Innovations in oral solid dosage forms

Dr. Klaus Pollinger and Dr. Martina Breuer, Aenova Group, explore the challenges of development and commercial manufacturing of oral solid dosage forms, from a CDMO perspective.

#HPAPI #CDMO #manufacturing #Solid dosage forms #R&D #production

Video

Alix Software

Feb. 24, 2023

STYL'One Tutorial - How to mount a specific shape tooling on a STYL'One Nano ?

MySTYL'One members exclusive!

Here is your Tutorial session for a better understanding of new features on Alix Software.

#tooling #software #alix #tutorial #STYL'One Nano

Announcement

MySTYL'One

Feb. 20, 2023

Resolving Tableting Challenges And Optimization Of The Tablet Compression Step Of An Immediate-Release Analgesic Formulation


MySTYL'One user exclusive!

This new bulletin available details a study on an optimization of the tablet compression process of an immediate-release analgesic formulation.

#analgesic formulation #compression properties #STYL'One #process

Feature article

Parmaceutical Networking

Feb. 20, 2023

STYL’One Contained Tableting Development

MEDELPHARM’s series of STYL’One tableting instruments provides a range of solutions to industry needs for containment and isolation to provide regulatory compliant levels of operator protection when working with highly potent active pharmaceutical ingredients (HPAPIs).

The need for effective containment solutions has become ever more pressing as increasing focus on small and large molecule synthesis create new classes of high toxicity HPAPIs, with consequent shift in emphasis from protection of the molecule from cross contamination or deviation from process to prioritization of protection of the environment and workers from contamination by the molecule.

#STYL'One evo #R&D #MEDELPHARM #DryCon #WipCon #containment

Page 1 of 12

Publish with us!